首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1477928

顱內壓 (ICP) 監測設備市場規模 - 按產品、技術、應用、最終用途和預測，2024 年至 2032 年

Intracranial Pressure (ICP) Monitoring Devices Market Size - By Offering, By Technology, By Application, By End-use & Forecast, 2024 - 2032

出版日期: 2024年02月27日 | 出版商:

Global Market Insights Inc. | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在醫療保健基礎設施的進步和對非侵入性監測方法的需求不斷成長的推動下，2024年至2032年全球顱內壓（ICP）監測設備市場規模的複合年成長率將達到6.8%。醫療保健設施的改善，尤其是在發展中地區，正在提高神經外科手術的可近性，包括顱內壓監測。此外，患者和醫療保健提供者對非侵入性或微創監測解決方案的偏好日益成長。這些趨勢標誌著向更有效、對患者友好的監測方案的轉變，推動了 ICP 設備的創新並擴大了其市場規模。

顱內壓 (ICP) 監測設備產業根據產品、技術、應用、最終用途和地區進行細分。

由於門診護理趨勢不斷增強，診所提供便利的監測服務，到 2032 年，診所業務將顯著改善。技術的進步促進了緊湊且方便用戶使用的監測解決方案的開發，這些解決方案與診所環境完美契合。隨著專業神經科診所數量的不斷增加以及對高效腦健康服務的關注，診所在管理神經系統疾病方面正變得至關重要，對更廣闊的市場前景做出了重大貢獻。

到 2032 年，腦出血領域的顱內壓 (ICP) 監測設備市場佔有率將大幅成長，原因是腦出血患者對持續監測的迫切需求，因為這有助於早期發現和介入。由於腦出血會帶來顱內壓升高的重大風險，因此對監測設備的需求很高，以防止繼發性腦損傷。非侵入式監測選項等技術進步進一步推動了 ICP 監測設備市場中這一細分市場的成長。

由於醫療基礎設施的蓬勃發展、老年人口的增加以及先進醫療技術的普及，亞太地區顱內壓 (ICP) 監測設備產業佔有率從 2024 年到 2032 年將呈現顯著的複合年成長率。該地區腦外傷和神經系統疾病發病率的增加也導致了這一趨勢。透過積極主動地實現醫療保健現代化以及對研發的大量投資，亞太地區將成為顱內壓 (ICP) 監測設備市場成長的關鍵貢獻者。

產業生態系統分析
產業影響力
- 成長動力
  - 各種神經系統疾病和創傷事故的盛行率不斷增加
  - 新技術的進步
  - 不斷成長的政府措施和政策
  - 提高認知和篩檢計劃
- 產業陷阱與挑戰
  - 這些監控設備的成本很高
  - 相關併發症和不良反應
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品分類，2018 年 - 2032 年

主要趨勢
產品與系統
解決方案和平台

第 6 章：市場估計與預測：按技術分類，2018 年 - 2032 年

主要趨勢
侵入性
- 腦室外引流（EVD）
- 微感測器ICP監測
非侵入性
- 經顱多普勒超音波檢查
- 鼓膜移位（TMD）
- 視神經鞘直徑
- 核磁共振/CT
- 腦電圖
- 眼底鏡檢查（視乳頭水腫）

第 7 章：市場估計與預測：按應用分類，2018 年 - 2032 年

主要趨勢
創傷性腦損傷
腦出血
腦膜炎
蜘蛛網膜下腔出血
腦脊髓液管理
偏頭痛
中風
腦積水
其他應用

第 8 章：市場估計與預測：按最終用途，2018 - 2032 年

主要趨勢
醫院
診所
診斷實驗室
其他最終用戶

第 9 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Brain4Care Inc.
CranioSense, LLC.
HeadSense Medical Ltd
Integra LifeScience Holdings Corporation
Johnson & Johnson
Luciole Medical AG
Medtronic plc
Natus Medical Incorporated
RAUMEDIC AG
Sophysa
Vittamed Corporation

簡介目錄

Product Code: 3339

Global Intracranial Pressure (ICP) Monitoring Devices Market size will record a 6.8% CAGR from 2024 to 2032, propelled by advancements in healthcare infrastructure and the increasing demand for non-invasive monitoring methods. Improved healthcare facilities, especially in developing regions, are enhancing access to neurosurgical procedures, including ICP monitoring. Furthermore, the preference for non-invasive or minimally invasive monitoring solutions is growing among patients and healthcare providers. These trends signify a shift towards more effective, patient-friendly monitoring options, driving innovation in ICP devices and expanding their market size.

The intracranial pressure (ICP) monitoring devices industry is segmented based on offering, technology, application, end-use, and region.

The clinics segment will encounter a marked upturn by 2032 due to the increasing trend toward outpatient care, where clinics offer convenient access to monitoring services. Advancements in technology have led to the development of compact and user-friendly monitoring solutions that align well with the clinic environment. With a rising number of specialized neurology clinics and a focus on efficient brain health services, clinics are becoming pivotal in managing neurological conditions, contributing significantly to the broader market outlook.

The intracranial pressure (ICP) monitoring devices market share from intracerebral hemorrhage segment will witness a considerable upsurge by 2032, fueled by the critical need for continuous monitoring in patients with this condition, as it helps in early detection and intervention. As intracerebral hemorrhage poses significant risks of increased intracranial pressure, the demand for monitoring devices is high to prevent secondary brain injury. Advancements in technology, such as non-invasive monitoring options, further drive the growth of this segment within the ICP monitoring devices market.

Asia Pacific intracranial pressure (ICP) monitoring devices industry share will exhibit a remarkable CAGR from 2024 to 2032, attributed to burgeoning healthcare infrastructure, a rising geriatric population, and expanding access to advanced medical technologies. The region's increasing incidence of traumatic brain injuries and neurological disorders also contributes to this trend. With a proactive approach to healthcare modernization and substantial investments in research and development, Asia Pacific will stand as a key contributor to the growth of the intracranial pressure (ICP) monitoring devices market.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
  - 1.5.2.1 Paid sources
  - 1.5.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of various neurological disorders and traumatic accidents
  - 3.2.1.2 Advancements in new technologies
  - 3.2.1.3 Growing government initiatives and policies
  - 3.2.1.4 Rising awareness and screening programs
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with these monitoring devices
  - 3.2.2.2 Related complications and adverse effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Offering, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Products & systems
5.3 Solutions & platforms

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Invasive
- 6.2.1 External ventricular drainage (EVD)
- 6.2.2 Microtransducer ICP monitoring
6.3 Non-invasive
- 6.3.1 Transcranial doppler ultrasonography
- 6.3.2 Tympanic membrane displacement (TMD)
- 6.3.3 Optic nerve sheath diameter
- 6.3.4 MRI/CT
- 6.3.5 Electroencephalography
- 6.3.6 Fundoscopy (Papilledema)

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Traumatic brain injury
7.3 Intracerebral hemorrhage
7.4 Meningitis
7.5 Subarachnoid hemorrhage
7.6 CSF management
7.7 Migraine
7.8 Stroke
7.9 Hydrocephalus
7.10 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Clinics
8.4 Diagnostic laboratories
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa